Here's how a project--such as reinventing the lab coat--can empower the minds of tomorrow.
Jim Cramer breaks down Amgen's deal to buy Otezla's rights from Celgene.
Equality in the workplace matters.
Amgen's deal to buy Otezla from Celgene should not deter the drugmaker's stock from gaining ground over the long haul.
Let's review the charts of SEM.
Elanco says the deal, which is subject to approval from regulators, would double the size of its companion animal business.
Medtronic's cardiac and vascular unit generates $2.79 billion in fiscal first-quarter revenue, surpassing analysts' estimates.
Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.